Causes and associated risk factors of heart failure patients in Aljouf region of Saudi Arabia

Despite advancing medical technology, Heart Failure (HF) is still a prevalent disease with high mortality and high health expenditure. To improve patient outcome and prognosis, it is important to identify the association of risk factors which leads to the co-morbid depression and anxiety in heart failure patients. Objectives: To determine the association of depression and/or anxiety with age, gender and ejection fraction in heart failure patients. Methods: It is an analytical cross sectional study including 323 CHF patients who visited the to the Faisalabad Institute of Cardiology hospital Out-Patient Department, 250 were males and 73 were females, mean age was 54.1 ± 9.2 years having 70 years as maximum and 25 years as minimum. Data collection was done using Hospital Anxiety and Depression Scale (HADS) questionnaire to assess depression and anxiety. Data was analyzed using SPSS version 24. For quantitative data, mean and standard deviation was calculated and for qualitative data frequency and percentages was calculated. To measure the association of anxiety and depression with age categories, ejection fraction and gender, chi square test was used. P values less than and equal to 0.05 were taken as significant. Results: No association of depression and anxiety with gender and Left Ventricular Ejection Fraction (LVEF) was observed. However, depression and anxiety were found to be significantly associated with age Conclusions: The study concluded that age is a strong risk factor of depression and anxiety in congestive heart failure patients. Multidisciplinary health care team approach and interventions are required to cater chronic heart failure (CHF) patients to address the psychological burden.

Download Full-text

Depression and associated risk factors among hypertensive patients in Primary Health Care Centers in Dammam, Kingdom of Saudi Arabia

Pan African Medical Journal ◽

10.11604/pamj.2021.38.278.27133 ◽

2021 ◽

Vol 38 ◽

Author(s):

Sumood Abdulbaqi Albasara ◽

Mohammad Shafee Haneef ◽

Mubashir Zafar ◽

Khawaja Ghulam Moinuddin

Keyword(s):

Risk Factors ◽

Health Care ◽

Saudi Arabia ◽

Primary Health Care ◽

Kingdom Of Saudi Arabia ◽

Hypertensive Patients ◽

Primary Health ◽

Associated Risk Factors ◽

Primary Health Care Centers ◽

Health Care Centers

Download Full-text

Prevalence of abdominal aorta aneurysm and associated risk factors in Abha city, Saudi Arabia

Saudi Surgical Journal ◽

10.4103/ssj.ssj_19_19 ◽

2019 ◽

Vol 7 (4) ◽

pp. 133

Author(s):

Abdullah Alhaizaey ◽

Ahmed Azazy ◽

Mohammed Asiry ◽

Mohammed Alsayed ◽

Mustafa Abbass ◽

...

Keyword(s):

Risk Factors ◽

Saudi Arabia ◽

Abdominal Aorta ◽

Abdominal Aorta Aneurysm ◽

Aorta Aneurysm ◽

Associated Risk Factors

Download Full-text

Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial

Canadian Journal of Cardiology ◽

10.1016/j.cjca.2019.01.022 ◽

2019 ◽

Vol 35 (9) ◽

pp. 1097-1105 ◽

Cited By ~ 9

Author(s):

Stephen J. Greene ◽

G. Michael Felker ◽

Anna Giczewska ◽

Andreas P. Kalogeropoulos ◽

Andrew P. Ambrosy ◽

...

Keyword(s):

Risk Factors ◽

Heart Failure ◽

Renal Dysfunction ◽

Acute Heart Failure ◽

Diuretic Resistance ◽

Heart Failure Patients

Download Full-text

Vitamin D Deficiency and Associated Risk Factors in Women from Riyadh, Saudi Arabia

Scientific Reports ◽

10.1038/s41598-019-56830-z ◽

2019 ◽

Vol 9 (1) ◽

Cited By ~ 1

Author(s):

Nora A. AlFaris ◽

Nora M. AlKehayez ◽

Fatema I. AlMushawah ◽

AbdulRhman N. AlNaeem ◽

Nadia D. AlAmri ◽

...

Keyword(s):

Risk Factors ◽

Vitamin D ◽

Saudi Arabia ◽

Vitamin D Deficiency ◽

Public Awareness ◽

Public Health Problem ◽

Hypovitaminosis D ◽

Cross Sectional Study ◽

Cross Sectional ◽

Associated Risk Factors

AbstractVitamin D deficiency is an epidemic public health problem worldwide. It is common in the Middle East and is more severe in women. This cross-sectional study was conducted to assess vitamin D deficiency and associated risk factors in women living in Riyadh, Saudi Arabia. Serum 25-hydroxyvitamin D (25(OH)D) was measured in 166 women aged 30–65 years. Socio-demographic, lifestyle and health status characteristics, as well as intake of selected dietary supplements, were collected. Weight and height were measured. Vitamin D deficiency (25(OH)D < 20 ng/mL) was reported in 60.2% of participants. Mean of serum 25(OH)D was 20.7 ng/mL. Older age and taking the supplements of vitamin D, multi-vitamins or calcium were identified as factors that associated with a lower risk of hypovitaminosis D. A national strategy is needed to control a hypovitaminosis D crisis in Saudi Arabia. This could be accomplished by raising public awareness regarding vitamin D, regulating and enhancing vitamin D fortification and supplementation and screening vitamin D status among women at high risk.

Download Full-text

Anemia in Heart Failure Patients

ISRN Hematology ◽

10.5402/2012/246915 ◽

2012 ◽

Vol 2012 ◽

pp. 1-9 ◽

Cited By ~ 21

Author(s):

Michael G. Alexandrakis ◽

George Tsirakis

Keyword(s):

Risk Factors ◽

Heart Failure ◽

Common Disease ◽

Blood Transfusions ◽

Functional Iron Deficiency ◽

Severe Morbidity ◽

Inflammatory Cascade ◽

Heart Failure Patients ◽

Erythropoietin Production ◽

Frequent Reason

Heart failure is a very common disease, with severe morbidity and mortality, and a frequent reason of hospitalization. Anemia and a concurrent renal impairment are two major risk factors contributing to the severity of the outcome and consist of the cardio renal anemia syndrome. Anemia in heart failure is complex and multifactorial. Hemodilution, absolute or functional iron deficiency, activation of the inflammatory cascade, and impaired erythropoietin production and activity are some pathophysiological mechanisms involved in anemia of the heart failure. Furthermore other concomitant causes of anemia, such as myelodysplastic syndrome and chemotherapy, may worsen the outcome. Based on the pathophysiology of cardiac anemia, there are several therapeutic options that may improve hemoglobin levels, tissues’ oxygenation, and probably the outcome. These include administration of iron, erythropoiesis-stimulating agents, and blood transfusions but still the evidence provided for their use remains limited.

Download Full-text